Zymeworks Inc. ($ZYME)
Filing Information
| Accession Number | 0001193125-26-011885 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 13, 2026 |
| Document Date | Jan 12, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
224,452
Total Value
$138,761.82
P&L
+inf% (+$4,267,560.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP & Chief Operating Officer | Common Stock | โ | Jan 12, 2026 | Exercise/Conversion | 17,666 | $0.00 | $0.00 | 139,033 | Direct | โ | View Details | |
EVP & Chief Operating Officer | Common Stock | โ | Jan 12, 2026 | Sale | 6,120 | $22.67 | $138,761.82 | 132,913 | Direct | โ | View Details | |
EVP & Chief Operating Officer | Restricted Stock Unit | Derivative | Jan 12, 2026 | Exercise/Conversion | 17,666 | $0.00 | $0.00 | 35,334 | Direct | โ | View Details | |
EVP & Chief Operating Officer | Stock Option (Right to Buy) | Derivative | Jan 12, 2026 | Grant/Award | 70,000 | $0.00 | $0.00 | 70,000 | Direct | โ | View Details | |
EVP & Chief Operating Officer | Restricted Stock Unit | Derivative | Jan 12, 2026 | Grant/Award | 47,000 | $0.00 | $0.00 | 47,000 | Direct | โ | View Details | |
EVP & Chief Operating Officer | Performance Stock Unit | Derivative | Jan 12, 2026 | Grant/Award | 66,000 | $0.00 | $0.00 | 66,000 | Direct | โ | View Details |